![]() ![]() ![]() The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested performance is not an indicator of future actual results. Maybe, the worst is behind the company, and the accretive acquisitions will enhance the stock’s potential.ĭisclaimer: The TipRanks Smart Score performance is based on backtested results. Importantly, it has regained 29% in just the past 30 days. Viatris stock has lost 18% of its market capitalization over the past year. Viatris’ average price forecast of $12.71 implies 12.9% upside potential.įollowing the news flow yesterday, Piper Sandler analyst David Amsellem upgraded Viatris from Sell to Hold with a price target of $10. Turning to Wall Street, analysts are cautiously optimistic about Viatris stock and have a Moderate Buy consensus rating, which is based on two Buys and five Holds. It continues to expect total revenue to be in the range of $16.2 billion – $16.7 billion. Positively, despite currency and inflationary headwinds, the company reiterated its full-year financial guidance. Meanwhile, revenues declined 10% year-over-year to $4.07 billion. Viatris reported adjusted earnings of $0.87 per share, beating analyst estimates of $0.84 per share. with Upjohn, Pfizer’s off-patent medicine division, in November 2020. is a global healthcare company formed by the merger of generic and specialty pharmaceuticals company Mylan N.V. The strategic move will make Oyster the backbone of Viatris’ new ophthalmology push, while Famy Life Sciences’ complementary ophthalmology portfolio will further bolster Viatris’ eyecare business.īased in the U.S., Viatris Inc. Oyster Point Pharma ( NASDAQ:OYST) agreed to be acquired by Viatris for $11 per share. Shares of Viatris ( NASDAQ:VTRS) gained 13% on November 7 after the company announced two acquisitions (Oyster Point Pharma and Famy Life Sciences) to expand its eyecare business concurrent with its Q3 earnings.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |